Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.

Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Brookmeyer R, Quinn TC, Laeyendecker O.

PLoS One. 2013;8(2):e55525. doi: 10.1371/journal.pone.0055525. Epub 2013 Feb 20.

2.

Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.

Hauser A, Santos-Hoevener C, Meixenberger K, Zimmermann R, Somogyi S, Fiedler S, Hofmann A, Bartmeyer B, Jansen K, Hamouda O, Bannert N, Kuecherer C.

PLoS One. 2014 Jun 3;9(6):e98038. doi: 10.1371/journal.pone.0098038. eCollection 2014.

3.

Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.

Longosz AF, Morrison CS, Chen PL, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):390-6. doi: 10.1097/QAI.0000000000000006.

4.

Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.

Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, Gray RH, Quinn TC, Eshleman SH, Laeyendecker O.

AIDS Res Hum Retroviruses. 2014 Apr;30(4):339-44. doi: 10.1089/AID.2013.0169. Epub 2013 Oct 25.

5.

Antibody maturation and viral diversification in HIV-infected women.

James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH.

PLoS One. 2013;8(2):e57350. doi: 10.1371/journal.pone.0057350. Epub 2013 Feb 27.

6.

Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.

Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, Eshleman SH; Partners in Prevention HSV/HIV Transmission Study Team.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1177-83.

7.

Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.

Marinda ET, Hargrove J, Preiser W, Slabbert H, van Zyl G, Levin J, Moulton LH, Welte A, Humphrey J.

J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):496-9.

PMID:
20306555
8.

Short Communication: The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection.

Wendel SK, Longosz AF, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Quinn TC, Laeyendecker O.

AIDS Res Hum Retroviruses. 2017 Apr;33(4):325-327. doi: 10.1089/AID.2016.0105. Epub 2017 Jan 11.

PMID:
27875908
9.

Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay.

Hayashida T, Gatanaga H, Tanuma J, Oka S.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):495-8. doi: 10.1089/aid.2007.0150.

PMID:
18327979
10.

Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.

Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH; Multicenter Aids Cohort Study Macs.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):816-22. doi: 10.1089/AID.2011.0258. Epub 2011 Dec 1.

11.

Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.

Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O.

PLoS One. 2013 Dec 27;8(12):e82772. doi: 10.1371/journal.pone.0082772. eCollection 2013.

12.

Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.

Laeyendecker O, Church JD, Oliver AE, Mwatha A, Owen SM, Donnell D, Brookmeyer R, Musoke P, Jackson JB, Guay L, Nakabiito C, Quinn TC, Eshleman SH.

PLoS One. 2010 Oct 11;5(10):e13259. doi: 10.1371/journal.pone.0013259.

13.

Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection.

Wang R, Weng J, Moyo S, Pain D, Barr CD, Maruapula D, Mongwato D, Makhema J, Novitsky V, Essex M.

AIDS Res Hum Retroviruses. 2013 Jun;29(6):901-6. doi: 10.1089/AID.2012.0294. Epub 2013 Apr 19.

14.

Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.

Duong YT, Qiu M, De AK, Jackson K, Dobbs T, Kim AA, Nkengasong JN, Parekh BS.

PLoS One. 2012;7(3):e33328. doi: 10.1371/journal.pone.0033328. Epub 2012 Mar 27.

15.

Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007.

Xu J, Wang H, Jiang Y, Ding G, Jia M, Wang G, Chu J, Smith K, Sharp GB, Chen RY, Jin X, Dong R, Han X, Shang H, Wang N.

Int J Infect Dis. 2010 Jul;14(7):e608-12. doi: 10.1016/j.ijid.2009.09.004. Epub 2010 Jan 25.

16.

Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis.

Laeyendecker O, Redd AD, Nason M, Longosz AF, Karim QA, Naranbhai V, Garrett N, Eshleman SH, Abdool Karim SS, Quinn TC.

J Infect Dis. 2015 Sep 1;212(5):754-9. doi: 10.1093/infdis/jiv110. Epub 2015 Feb 23.

17.
18.

Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.

Mullis CE, Munshaw S, Grabowski MK, Eshleman SH, Serwadda D, Brookmeyer R, Nalugoda F, Kigozi G, Kagaayi J, Tobian AA, Wawer M, Gray RH, Quinn TC, Laeyendecker O.

AIDS Res Hum Retroviruses. 2013 Aug;29(8):1146-50. doi: 10.1089/AID.2012.0105. Epub 2013 May 29.

19.

Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays.

Hladik W, Olara D, Mermin J, Moore D, Were W, Alexander L, Downing R.

AIDS Res Hum Retroviruses. 2012 Jan;28(1):95-9. doi: 10.1089/AID.2010.0347. Epub 2011 Mar 11.

PMID:
21314476
20.

Comparison among the BED capture enzyme immunoassay test and AxSYM avidity index assay for determining recent HIV infection and incidence in two Voluntary Counselling and Testing Centres in Northeast Brazil.

Salustiano DM, Lima KO, Cavalcanti AM, Diaz RS, Lacerda HR.

Braz J Infect Dis. 2014 Jul-Aug;18(4):449-53. doi: 10.1016/j.bjid.2014.03.001. Epub 2014 Apr 26.

Supplemental Content

Support Center